Test Catalog

Test Id : FABP2

Order This Test

Allergic Bronchopulmonary Aspergillosis Panel II

Download
Overview

Test Catalog

Method Name
A short description of the method used to perform the test

ImmunoCAP 1000

ImmunoCAP FEIA

Enzyme immunoassay (FEIA)

NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.

No

Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test

Allergic Bronchopulmonary Panel II

Aliases
Lists additional common names for a test, as an aid in searching

Allergic Bronco Panel

Specimen Type
Describes the specimen type validated for testing

Serum

Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing

Specimen Type: Serum

Container/Tube: Red or SST

Specimen Volume: 1.5 mL

Collection Instructions: Draw blood in a plain, red-top tube(s) or serum gel tube(s). Spin down and send 1.5 mL of serum refrigerate in a plastic vial.

Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the testing laboratory. The minimum volume is sufficient for one attempt at testing.

1 mL

Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected

Lipemia Mild OK; Gross Reject

Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 28 days
Frozen 365 days
Ambient 7 days

Clinical Information
Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

Aspergillus fumigatus IgG

Antibody levels greater than the reference range indicate that the patient has been immunologically sensitized to the antigen. The significance of eleveated IgG depends on the nature of the antigen and the patient’s clinical history.

 

Aspergillus fumigatus Mix Gel Diffusion     

The gel diffusion method was used to test this patient's serum for the presence of precipitating antibodies (IgG) to the antigens indicated.  These antibodies are serological markers for exposure and immunological sensitization.  The clinical significance varies, depending on the history and symptoms.  This test was developed and its performance characteristics determined by Viracor Eurofins.  It has not been cleared or approved by the FDA

Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

Total IgE

Age Related      Reference Range

1-11 months                  0-12

      1 year                     0-15

      2 year                     1-29

      3 year                     4-35

      4 year                     2-33

      5 year                     8-56

      6 year                     3-95

      7 year                     2-88

      8 year                     5-71

      9 year                     3-88

     10 year                     7-110

11-14 year                     7-111

15-19 year                    6-96

20-30 year                    4-59

31-50 year                    5-79

51-80 year                    3-48

 

Aspergillus fumigatus IgE

Reference Range: <0.35 kU/L   

Aspergillus fumigatus IgG

Reference Range: <46 mcg/mL

Aspergillus fumigatus Mix Gel Diffusion

Reference Range: Negative

 

Interpretation
Provides information to assist in interpretation of the test results

 

Aspergillus fumigatus IgE

Class    IgE (kU/L)         Comment

0          <0.10                Negative

0/1        0.10-0.34           Equivocal/Borderline

1          0.35-0.69           Low Positive

2          0.70-3.49           Moderate Positive

3          3.50-17.49         High Positive

4          17.50-49.99       Very High Positive

5          50.00-99.99       Very High Positive

6          >99.99              Very High Positive

 

PDF Report
Indicates whether the report includes an additional document with charts, images or other enriched information

No

Day(s) Performed
Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.

Monday through Friday

Report Available
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.

5 to 9 days

Performing Laboratory Location
Indicates the location of the laboratory that performs the test

Eurofins Viracor

Fees :
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.

  • Authorized users can sign in to Test Prices for detailed fee information.
  • Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
  • Prospective clients should contact their account representative. For assistance, contact Customer Service.

Test Classification
Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.

Aspergillus fumigatus IgG

This test was developed and its performance characteristics determined by Eurofins Viracor. It has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information
Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

CPT codes are provided by the performing laboratory.

86331

86001

86003

82785

LOINC® Information
Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.

Test Id Test Order Name Order LOINC Value
FABP2 Allergic Bronchopulmonary Panel II Not Provided
Result Id Test Result Name Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
Z3248 Total IgE In Process
Z3249 Aspergillus fumigatus IgE 6025-1
Z3250 Class 102153-4
Z3251 Aspergillus fumigatus IgG 26954-8
Z3252 A. fumigatus Mix Gel Diffusion 23821-2

Test Setup Resources

Setup Files
Test setup information contains test file definition details to support order and result interfacing between Mayo Clinic Laboratories and your Laboratory Information System.

Excel | Pdf

Sample Reports
Normal and Abnormal sample reports are provided as references for report appearance.

Normal Reports | Abnormal Reports

SI Sample Reports
International System (SI) of Unit reports are provided for a limited number of tests. These reports are intended for international account use and are only available through MayoLINK accounts that have been defined to receive them.

SI Normal Reports | SI Abnormal Reports

Test Update Resources

Change Type Effective Date
Test Status - Test Resumed 2022-12-29
Test Status - Test Delay 2022-12-14